Horizon Discovery offers advanced genome editing tools, including CRISPR and RAAV technologies, to facilitate the development of personalized medicine through precise gene manipulation. Their services include free CRISPR reagents for knockout generation, extensive intellectual property access, and support for researchers via their GenAssist and Guidebook resources. The company emphasizes their unique capability to combine multiple gene editing platforms to enhance research efficiency and outcomes.